-
-
Endpoints News (September 29, 2022) Senate passes bill to rework animal testing requirements for drug developers
The US Senate passed via unanimous consent on Thursday afternoon a bipartisan bill that would alter a federal mandate for animal testing on new drugs, but stops short of removing animal testing entirely.
{Press Release} (September 29, 2022) Booker Celebrates Passage of FDA Modernization Act to Ban Animal Testing Mandates
“The passage of my bill will avoid the needless suffering of countless animals, now that experimental drug testing can be done with modern non-animal alternatives that are more scientifically relevant,” said Senator Booker. “This legislation brings us one step closer to eliminating the cruel practice of unnecessary animal testing.”
Los Angeles Times (September 28, 2022) California bans unnecessary pesticide, chemical testing on dogs and cats
California will ban the testing of harmful chemicals on dogs and cats, effectively becoming the first state in the U.S. to remove the option for companies seeking to learn about the harmful effects from their products. Gov. Gavin Newsom signed the bill into law Monday along with several other bills aimed at protecting animal welfare in the state. The law goes into effect Jan. 1.
NBC Bay Area (September 26, 2022) Gov. Gavin Newsom Signs Several Laws to Protect Animal Welfare
Governor Gavin Newsom on Monday signed several measures that he says will advance animal welfare in the state, his office announced. Senate Bill 879, also known as the PET Act (Prohibiting Extraneous Testing) was put forth by Senator Scott Wiener (D-SF) and aims to end “unnecessary” toxicological testing on dogs and cats.
The Hill (September 22, 2022) FDA user fee reauthorization added to bill to prevent government shutdown
Sen. Richard Burr (R-N.C.) on Thursday said the five-year reauthorization of the Food and Drug Administration’s (FDA) user fee program will be included in the stopgap spending bill meant to prevent a government shutdown.
Endpoint News (September 22, 2022) ‘Practically clean’ FDA user fees reauth will be included in spending bill wrapping up next week
The long and winding road to reauthorizing FDA’s quinquennial user fees for prescription drugs, generics, biosimilars and medical devices finally has a light at the end of it. While negotiations are still ongoing on which policy riders (accelerated approval reforms, et. al.) may be included, a senior GOP committee aide confirmed to Endpoints News Thursday that at the very least, an agreement has been reached for the FDA user fee deals, which are good through 2027, to be included in the continuing resolution.
Axios (September 22, 2022) Deal reached to renew FDA user fee programs
Senate and House health committee leaders on Thursday reached an agreement to renew programs that fund key Food and Drug Administration programs for another five years. Why it matters: Without congressional action by the end of the month, the FDA would have had to start sending out furlough notices to staff and slow down critical work like drug approvals.
-
- You must be logged in to reply to this topic.